Startups
7 Exciting Startup Opportunities In The Health Industry
As some of you know from my post here on Addicted2Success I have recently found out that I have a food intolerance, and it has changed the way I view health. While going through this process I have discovered that there is a phenomenal startup opportunity that is only beginning in the health space.
Let’s face it; people are going to continue to be Fat, Sick, And Nearly Dead (words made famous by Joe Cross) for the foreseeable future until there is a new era born. I truly believe that like the information age, the start of a health revolution is on its way.
This new era will help any budding entrepreneur (also known as healthpreneur) create value and make considerable amounts of money. Take a look around and tell me how many people you see that are smoking, drinking soft drink, eating greasy takeaway food or who are overworked.
If you’re like me, you see people like this everywhere, and so it’s your chance as an entrepreneur to help them and create a successful startup at the same time.
Below are seven exciting opportunities that I have seen if you want to establish a startup in the health industry:
1. Food intolerance eating
This first point is one that I have quickly become an expert on and I honestly thought that in the 21st century it would have already been solved but clearly it has not. The main area of opportunity is in the takeaway space. It’s very difficult to find takeaway food or restaurants that can tell you exactly what’s in their food or that even care.
For any entrepreneur who can start a restaurant that addresses this issue, you will be in a niche of your own with thousands of people as your customer. I have to admit that I was fairly naive and didn’t realise how many people have some sort of food intolerance or allergy.
In terms of technology, there is a few apps and websites but none of them are as simple as say Zoomato or the Uber App. Anyone that is passionate and puts the time into creating communities, apps or websites in this field will do very well.
Some people make the mistake of seeing one or two brands that represent their niche and thinking there is no opportunity. This is entirely the wrong way to think. Start thinking how you can do something better with loads of passion and you will leave the opposition for dead.
2. Medical records
So I recently changed doctor here in Australia and had the fun task of trying to get access to my medical records. I soon discovered that this was a major challenge and was centred around the fax machine. While the privacy requirement in the medical industry is a tough one to crack, it’s been done for medical payments so it can definitely be done for medical information.
During my experience, I had multiple specialists, doctors and pathology centres all trying to liaise with one another via phone and fax with great difficulty. If I had been seriously sick, I would have died before they had figured out who sent what fax to whom.
Imagine a world where all your medical records were hosted securely in the cloud, and you or your doctor could securely log in at any time and look at the information. You could also share food diaries, treatment journals, side effect lists, photos of medical conditions and many other things with your GP.
When you go into see your doctor next time in person, they can already see everything about what you have been doing and everything that has occurred in the medical part of your life. Imagine then that this could synchronise with your Fitbit, heart rate monitor or any other health device to give your doctor the full picture in real-time.
There is so much opportunity for entrepreneurs in the medical records space that it’s not funny.
3. Health education in schools
Yet another great opportunity for healthpreneurs is education in schools. I think most of you would agree that we don’t figure out how to be healthy until we are adults because our schools teach us out of date concepts that leave a lot of blanks for children.
We need more passionate entrepreneurs going into schools and teaching from the ground up why we should understand what foods to eat and even how to grow them ourselves. I am not saying that no one has thought of this idea (such as Jamie Oliver) I am saying that there is still heaps of opportunity to take it further.
4. Health Advice / Coaching
Most of the practitioners in the health industry lack the knowledge, passion and delivery method to be able to make reach a larger audience and grow a substantial size business. Again, I am not saying there is no one that provides advice or coaching in the health industry, but what I am saying is there is only a small few who do it well.
The majority of the advice that you get from an expert who has a degree in the field is through face-to-face appointments. Just like the finance industry, this is very inefficient, and there are much better online methods to deliver coaching.
More and more I am seeing financial planners use online webinars or Skype to deliver their advice, and I think this is the way to effectively scale advice in the health space. The benefits are obvious to the end user, reduced costs and easier to manage for busy people.
If you have some knowledge about health, consider doing a startup that takes full advantage of the web and try to provide advice that isn’t biased and gives people options. If you nail this formula, you will have a very profitable business.
5. Supplements – hear me out on this one
Yes, there are thousands of companies that make supplements and most of them are not very good. I know what you’re thinking, “Tim supplements have been around for decades.” I agree they have, but supplements that actually work, clearly show what’s in them and are made from natural, organic ingredients are hard to find.
The need for supplements is growing every year because the quality of our food supply is diminishing; our free time is decreasing, and our diets are getting worse. Don’t let any of these things give you a negative feeling, they are positive because with problems come opportunities for entrepreneurs.
Supplement companies and marketers are not always the most honest people, and so there is an opportunity for more startups to enter this space and create magic. In the western market, there are not a lot of companies that use Chinese Medicine practices and ingredients.
There is clearly an opportunity to make use of the thousands of years of wisdom that the Chinese have around health. Just take a trip to China and see the males who are over eighty years old and have no grey hair or a sign of baldness or wrinkles in sight. IT WILL AMAZE YOU!
6. All things juicing
I am only just starting to see a few startups in Australia, and the USA take advantage of the benefits that we all know exist with any form of juicing. There seem to be a few companies making very healthy profit margins selling convenient juice fasts, but I still think there is a lot more opportunity in this space for entrepreneurs.
In terms of places to buy juice, there is still not that many that exist. A lot of them are very much just the vanilla offerings and there are no wheatgrass, cold press or organic options. Bring your startup into the world of juicing and you might find yourself having some of the success that healthpreneur Joe Cross has had.
7. The labelling of food
One of the biggest challenges in the health industry is around labelling of foods. Yes, it has been addressed at a beginner level but there is still a long way to go. For example, many processed foods will say they contain garlic but a lot of people like me want to know is how much garlic is present.
There are also many cases where ingredients are given colourful names to try and hide what they truly are. Any entrepreneur who can address some of these challenges, produce products with better labelling, and find ways for consumers to examine what their food is made of, will do very well in this new health economy.
One company that has scratched the surface of this whole concept is Consumer Physics from Israel who have created a spectroscopy device that allows you to know what is in virtually anything from food to furniture, to your car.
There are many more opportunities in the labelling area of the health industry, and I look forward to seeing those inventions in the coming years.
***Final Thought***
So there you have it, my seven suggestions for startups you can create around the opportunities that exist in the health industry. Don’t just read this article and then say to yourself “that’s nice Tim, maybe I will look at these opportunities one day. “
The time is now in this new health era we are entering, and if you have something to bring of value, then you should establish your startup now and become a front runner. If you don’t have anything to bring to the health industry then check out the online / tech space, there are loads of opportunities for almost anyone there.
If you have some other ideas that I have missed or you would like to give me your opinion then feel free to visit my Facebook Page, Twitter or leave a comment below, and I will respond.
Startups
SaaS Pricing Strategy: Per-Seat, Usage or Tiered, and How to Choose Before Launch
This SaaS pricing strategy guide compares real per-seat, usage and hybrid price points, then walks a clinic software example through a 7-step launch pricing plan.

A SaaS pricing strategy is how you decide what your software charges for, how much, and how the bill grows as a customer gets more value from it, usually through per-seat, usage-based or tiered pricing. To choose, find the one unit that grows when your customer wins (your value metric), charge on that unit, and package it into two or three clear plans before you launch.
Seats fit tools where every person gets value. Usage fits APIs, automation and anything metered. Tiers fit products where customers need different levels of capability. Most mature companies end up with a hybrid of two.
Rob Walling has helped a lot of bootstrapped founders through this exact decision, and his five-minute breakdown above is the fastest primer I know on the common SaaS pricing models.
Here’s what I see over and over. A founder spends nine months building the product and about nine minutes on the pricing page. They open three competitor sites, pick a number in the middle and ship it. Then they wonder why every deal feels like a negotiation. Pricing isn’t a finance task you bolt on at the end. It’s a product decision. It tells the market who you’re for and what you think you’re worth. Get the model right before launch and almost everything after gets easier, from sales to forecasting to fundraising.
SaaS Pricing Models Compared: Per-Seat, Usage-Based, Tiered and Hybrid
Real examples from public pricing pages, checked November 17, 2026:
| Model | How the bill grows | Real example | Best for |
|---|---|---|---|
| Per-seat | With the number of users | Slack Pro: $8.75 per user per month, billed monthly | Collaboration tools, CRMs, design tools |
| Usage-based | With consumption | Twilio: $0.0083 per US text message; Stripe: 2.9% + 30 cents per domestic card charge | APIs, infrastructure, payments, AI |
| Tiered | Customer moves up a plan for more features or limits | Starter, Pro and Enterprise plans | Products serving very different customer sizes |
| Hybrid | A base fee or seats, plus usage | Intercom: helpdesk from $29 per seat per month, plus $0.99 per outcome for its Fin AI Agent | Products with two clear value drivers |
Look at Intercom for a second, because it’s the clearest picture of where SaaS pricing is heading. Humans get charged by the seat. The AI agent that replaces some of their work gets charged by the result. The pricing follows the value, not the org chart.
Per-Seat Pricing: When It Works and When It Breaks
Per-seat pricing is the default for a reason. Buyers understand it, finance teams can budget for it and your revenue grows as the customer hires. It works when each extra person genuinely gets value from the product.
It breaks in two places. First, customers start sharing logins to keep the bill down, which quietly caps your growth. Second, automation. As pricing researcher Kyle Poyar has put it (quoted in Race to Scale’s guide), the more successful a product is, the fewer user seats a customer needs. If your software saves a team from hiring two people, per-seat pricing punishes you for doing your job well. I wrote about this shift in more depth when seat-based pricing started cracking under AI, and it’s only accelerating.
Usage-Based Pricing: When It Works and When It Breaks
Usage pricing lets a customer start small and grow without a big upfront decision. Expansion is built in: when they use more, they pay more, and they usually don’t mind because they’re getting more.
The downsides are predictability on both sides. Your revenue swings month to month, and buyers get nervous when they can’t guess next quarter’s bill. The fix most companies land on is a committed minimum plus overage, or a monthly cap. If a customer can’t explain the bill to their finance lead in one sentence, simplify it.
Tiered Pricing: When It Works and When It Breaks
Good, better, best. Tiers let you serve a solo founder and a 200-person company with one product. They also create a natural upgrade path.
They break when the differences between tiers are cosmetic. If nobody needs what’s in the higher plan, everyone sits on the cheapest one forever. Put real workflow needs in the upper tiers: higher limits, SSO, advanced reporting, priority support. Things a growing customer will genuinely hit.
How to Choose a SaaS Pricing Strategy Before Launch
- Find your value metric. Ask: what goes up when my customer is winning? Contacts, messages sent, invoices processed, locations, revenue handled. That’s what you should charge on.
- Run it through three tests. Can the customer understand it instantly? Does it grow with the value they get? Can you actually measure and bill it without manual work? A slightly imperfect metric you can track beats a perfect one you can’t.
- Check your costs per unit. Your price has to cover what it costs to serve each customer and still leave margin for acquiring the next one. If the unit economics don’t work at your planned price, no pricing model will save you. This matters most for AI products, where every use has a real compute cost.
- Talk to 10 to 20 target buyers about price. Don’t ask “would you pay $X?” Use the Van Westendorp questions instead: at what price is this too cheap to trust, a bargain, getting expensive, and too expensive to consider? The overlaps show you a sensible range.
- Package two or three plans. One for getting started, one for the customer you most want, and a “talk to us” plan for big accounts. More than that and buyers freeze.
- Launch a little higher than feels comfortable. It’s far easier to offer a discount or an early-customer deal than to raise prices on people who joined cheap.
- Decide now how you’ll treat early customers when prices change. Grandfathering them for a set period builds loyalty and makes the next price increase painless.
A Worked Example: Pricing a Clinic Scheduling Tool
Say you’re launching booking software for physical therapy clinics. A typical customer has 3 front-desk staff, 1 location and about 400 appointments a month. Here are three ways to price it (example numbers only):
| Model | Price | Monthly bill for this clinic |
|---|---|---|
| Per seat | $25 per staff user | $75 |
| Per location (flat tier) | $149 per location | $149 |
| Usage | $0.40 per booked appointment | $160 |
Per seat looks safe, but the front desk is the one team your product shrinks, so you’d be charging on the thing you’re eliminating. Usage tracks value nicely, yet clinic owners hate a bill that jumps in busy months. Per location wins here: it’s simple, it’s predictable, and it grows when the customer opens a second clinic, which is exactly when they’re winning. Add a higher tier with SMS reminders and insurance checks, and you have a clean upgrade path. That’s the kind of thinking I’d want before launch.
Common SaaS Pricing Strategy Mistakes
- Copying a competitor’s page. You don’t know if their pricing is working. Neither do they, half the time.
- Underpricing to look friendly. Cheap pricing tends to attract the customers who cost the most to support and churn the fastest.
- Too many plans or too many variables. Confused buyers don’t buy.
- Freemium without a reason. A free plan only works if free users invite paying users or naturally hit a limit. Otherwise a free trial is usually cleaner.
- Never revisiting it. Review your pricing at least once a year, or whenever the product adds real value.
How Your Pricing Model Shows Up in Your Metrics
Your model changes how investors read your numbers. Seat and tier revenue is recurring and easy to forecast. Usage revenue grows faster in good accounts but moves around more, which is why founders need to be careful about how they report ARR vs MRR when part of the bill is variable. Pick a model you can explain cleanly in a board deck, not just on a pricing page.
Frequently Asked Questions
What is the best pricing strategy for SaaS?
There’s no single best one. The best SaaS pricing strategy charges on the unit that grows with customer value, packaged into two or three simple plans. For many products today that’s a hybrid of a base subscription plus usage.
What are the main SaaS pricing models?
The main SaaS pricing models are per-seat (per user), usage-based (pay for what you consume), tiered (feature or limit plans), flat-rate and hybrid combinations. Freemium and free trials are acquisition tactics layered on top.
How do I price my SaaS product before launch?
Pick a value metric, confirm your cost to serve each customer, interview 10 to 20 target buyers using willingness-to-pay questions, then launch two or three plans slightly higher than feels comfortable.
Should a SaaS startup offer a free plan?
Only if free users spread the product to paying users or naturally outgrow the free limits. If not, a 14- or 30-day free trial is usually simpler to run and cheaper to support.
What is a value metric in SaaS pricing?
A value metric is the unit you charge for, such as users, contacts, messages or locations. A good one rises as the customer gets more value, so your revenue grows with their success.
How often should a SaaS company change its pricing?
Review it at least once a year and after any major product release. Change it when the data says customers get more value than they pay for, and give existing customers notice.
Startups
Pre-Seed Funding: What It Is, Who Writes the Checks, and How It Differs From Seed
How pre-seed funding differs from seed, who usually writes the checks, what investors want to see, and why most deals use convertibles.
Pre-seed funding is the earliest capital a startup raises before a seed round, usually to turn an idea into a validated concept or a minimum viable product. There is no single official definition. Carta’s fundraising guide, updated October 7, 2026, describes it as funding that comes before seed, and notes that the startup community still debates the edges. In practice, the money often comes from friends and family, angel investors, accelerators and some pre-seed venture funds, and it is usually raised on a convertible instrument rather than a priced equity round.
You’ll also hear it called a pre-seed round or, loosely, an angel round. Seed is the next named stage, when investors typically want a working product and early traction, not just a thesis. This is education, not a fundraising offer or legal advice. Talk to a startup attorney before you take money, including from people you know.
Pre-seed vs seed, in plain terms
Carta’s comparison is a useful starting map, not a law. Pre-seed is about validating the problem and building the first product and team. Seed is about early traction, a growing user base and, often, the start of revenue. The check writers shift as you move from friends, family, angels and accelerators toward seed-stage funds, though angels can show up in both rooms.
| Pre-seed | Seed | |
|---|---|---|
| Job of the money | Test the idea, build an MVP, form the initial team | Push toward product-market fit and early growth |
| Typical company stage | Idea, prototype or early MVP, often pre-revenue | Working product with early traction |
| Who usually writes checks | Friends and family, angels, accelerators, some pre-seed funds | Seed-stage VCs, larger syndicates, still some angels |
| How the deal is often documented | Mostly convertible (a SAFE or a note) | Convertible or a priced preferred-stock round |
Some companies now close a small priced “pre-seed” round. That exists, but it is still the exception at this stage. If someone is quoting a firm valuation and issuing preferred stock this early, treat that as a priced round with a pre-seed label, and have counsel read the documents.
Who writes pre-seed checks
Four sources show up again and again. Friends and family can be the first money in, because they are betting on you before the market has. That intimacy is also the risk. A messy gift, a loan with no terms, or an undefined ownership claim can sour a relationship and dirty the cap table. Have an attorney document it, and be honest about the chance the money does not come back.
Angel investors and syndicates write checks because they believe the founder, the problem and the early plan. They may invest as individuals or through a group that pools smaller checks. Accelerators and incubators typically invest a fixed amount as part of a program, often in exchange for a set percentage of the company, plus mentorship and a demo day. Pre-seed venture funds specialize in this stage and will expect a tighter story than your cousin will.
Equity crowdfunding is sometimes mentioned as another path. It is a regulated offering with its own rules, costs and disclosure. It is not a casual “post a campaign” substitute for counsel, and it is not the standard path for most pre-seed companies.
What pre-seed investors actually want to see
At this stage, investors are usually buying a problem, a team and a plan, not a revenue curve. Carta’s October 2026 guide puts it this way: early-stage investors look for a deep understanding of the problem, plus passion, unique expertise and resilience. They want a clear vision, and they want to believe you can execute before the product is finished.
In a pitch, that usually means you can explain who has the problem, why current options fail, why you are the person to work on it, and what you will build and learn with this money. A prototype, early user conversations or a waiting list helps. A finished product with paying customers is better, but many pre-seed companies do not have that yet, and pretending you do will not survive the first diligence call.
They also want to know what this raise is for. “We need money” is not a milestone. “Eighteen months to ship an MVP, test it with 50 users and decide whether to raise a seed round” is a thesis they can accept or reject.
How much to raise, and why the average is not a target
There is no universal pre-seed check size, and published ranges should be dated, because the market moves. Carta’s October 7, 2026 guide says most pre-seed rounds land between $150,000 and $1 million, and gives a typical example of about $250,000 to $1 million, with some rounds smaller or larger. Carta data in that same guide shows the average instrument is $276,000, with 18% of rounds in the $1 million to $2.5 million range as of the first quarter of 2026.
Those figures describe Carta’s dataset. They are not a recommendation for your company. The right amount is the one that buys enough runway to hit the next set of milestones. Carta’s guide suggests aiming for 12 to 24 months of runway: long enough to build, validate and reach the traction that can support a seed round, short enough that you are not selling more of the company than the stage warrants.
Raise too little and you’ll be fundraising again before you have results. Raise too much, too early, and you can over-dilute, or set a cap that makes the next round awkward. I would rather see a tight budget tied to a milestone than a raise sized off someone else’s average.
Most pre-seed deals are convertibles, not priced rounds
A priced equity round sets a valuation and issues preferred stock now. That takes time, legal fees and a cap table conversation many pre-seed companies are not ready for. Convertible instruments let an investor put money in now, in exchange for the right to receive equity later, usually at a discount or subject to a valuation cap when a priced round happens.
Y Combinator introduced the SAFE (Simple Agreement for Future Equity) in 2013. Carta’s State of Pre-Seed report, as cited in that October 2026 guide, found that SAFEs made up 93% of pre-seed rounds in the second quarter of 2026. Convertible notes are the older cousin: they are debt until they convert, which means they can carry interest and a maturity date.
The two instruments are not interchangeable, and the fine print on a cap, a discount, a most-favored-nation clause or a pre-money versus post-money SAFE can change who owns the company later. We walk through SAFE vs convertible note in a dedicated comparison, including how those terms work. This page will not retarget that debate. Have counsel choose and draft the instrument. Do not copy a template from a blog comment and call it done.
Get the cap table honest before anyone wires money
Investors will ask who owns the company today. If two co-founders have never written the split down, or an “advisor” was promised 5% over coffee, that is not a cap table. It’s a future fight. Before you raise, agree on a founder equity split you can defend, document it, and keep a simple record of every promise you’ve already made.
Carta’s guide also lists a clean cap table as part of preparing for a raise, and it is right. You do not need expensive software to start. You do need names, percentages, the instrument behind each claim and the date. If you have already taken friends-and-family money on vague terms, fix that with an attorney before you invite a professional investor into the same file.
Securities law sits underneath all of this. Selling equity or a convertible, even to people you know, can be a securities offering. Exemptions exist, and filings such as Form D may be part of the picture, but those are facts for counsel, not a checklist I’m going to pretend I can complete in a paragraph. Ask a lawyer who does early-stage work. If friends or family are involved, a tax professional should also look at whether the money is a gift, a loan or an investment.
You do not have to raise
Pre-seed funding is optional. Plenty of companies reach a first product with savings, revenue and a tight budget, then raise later or never. Outside capital is useful when speed matters and the milestone is clear. It is expensive when you are still searching for the problem, because you are selling ownership against a story that may change in six months.
If you do raise, treat the money as a responsibility. Spend it on the milestone you sold, keep a simple forecast, and assume you will have to explain every hire and every delay. The best pre-seed outcome is not a big announcement. It is arriving at the next stage with evidence, a clean cap table and enough ownership left that the next round is still worth doing.
Frequently Asked Questions
What is pre-seed funding?
Pre-seed funding is capital raised before a seed round, usually to validate an idea or build an MVP. Definitions vary. The money often comes from friends and family, angels, accelerators or pre-seed funds, typically on a SAFE or convertible note.
How is pre-seed different from seed?
Pre-seed is earlier. Investors are usually backing a problem, a team and a plan, often before revenue. Seed investors typically want a working product and early traction. Amounts, check writers and whether the round is priced also tend to shift.
How much pre-seed funding should I raise?
There is no universal number. Carta’s October 2026 guide says most pre-seed rounds land between $150,000 and $1 million, with an average instrument of $276,000 as of Q1 2026. Raise enough runway, often 12 to 24 months, to hit your next milestone.
Who invests at the pre-seed stage?
Common sources are friends and family, angel investors and syndicates, accelerators, and some funds that specialize in pre-seed. Equity crowdfunding is a regulated alternative, not a casual substitute. Document every check with counsel.
Do I need a SAFE or a convertible note?
Most pre-seed rounds use a convertible, and Carta reported SAFEs were 93% of pre-seed rounds in Q2 2026. A priced round is possible but less common this early. Ask an attorney which instrument fits. The two are not the same.
Should every startup raise a pre-seed round?
No. Raise if speed and a clear milestone justify selling ownership this early. If you can reach proof with savings or revenue, you may be better off waiting. Taking money from people you know still requires legal documents.
Startups
ARR vs MRR: Which Number Investors Actually Read (With Worked Examples)
A worked ARR vs MRR example, what each number should include, which one investors actually read, and the mistakes that make both figures lie.
ARR vs MRR is a timing question, not two different kinds of money. Monthly recurring revenue (MRR) is the normalized monthly value of your contracted subscription revenue. Annual recurring revenue (ARR) is that same recurring book of business expressed as a yearly run rate, most often as MRR times 12. Both leave out one-time fees. Neither is the cash you collected this month, and neither is the revenue line on a GAAP income statement.
You’ll hear finance folks use ARR in conversations with investors, boards and acquirers, and MRR when they look at last month’s new logos, upgrades and churn. If you only remember one distinction, remember this: ARR is the headline. MRR is the instrument panel.
What MRR includes, and what it doesn’t
MRR is the sum of the monthly value of active, paying subscriptions. A $99-a-month plan contributes $99. A $1,200 annual plan contributes $100, because you divide the contract by 12, even if the customer paid the whole year up front this morning. Discounts count at the amount actually billed, not the list price.
What you leave out matters as much as what you put in. One-time setup fees, implementation, professional services and other project work are not recurring, so they stay out of MRR. Free users and unpaid trials stay out until a payment actually starts. Usage or consumption charges that are not contractually committed are usually reported separately, not folded into MRR, unless you are explicitly reporting a usage-inclusive figure and saying so.
Those inclusion rules match how practitioners such as Stripe and the GASP metrics standard describe the number. MRR is a business-insights metric. It is representative of, but not identical to, recognized revenue.
The two meanings of ARR
ARR gets used in two ways, and you should know which one you’re reporting.
The first is annualized run rate: ARR equals MRR times 12. That is the common definition for companies that bill monthly or have a mix of monthly and annual plans, and it is the formula Stripe walks through in its ARR explainer. The second is the sum of annualized contract values, which shows up more often in businesses that sell mostly annual or multi-year contracts.
Both are valid if you apply them consistently. The GASP standard uses MRR times 12 so companies with different billing mixes can be compared on one basis. Pick a definition, write it down, and don’t switch it when the number needs to look bigger.
If you only sell annual deals, the two definitions should land in the same place once every contract is normalized. Say you have 20 customers, each on a $6,000 annual contract. MRR is $10,000, because $6,000 divided by 12 is $500, times 20. ARR is $120,000, whether you multiply that MRR by 12 or add the 20 contracts. The definitions start to diverge when you mix in usage, partial periods or a mid-year start and forget to annualize the same way twice. Some finance teams also report committed ARR or contracted ARR, meaning only signed, in-term subscription value, with uncommitted usage left out. If your headline includes a usage run-rate, say so. Investors will ask.
| MRR | ARR | |
|---|---|---|
| What it measures | Normalized monthly value of recurring subscriptions | That same recurring book, expressed as a yearly run rate |
| Common formula | Sum of monthly subscription values (annual contracts / 12) | MRR × 12, or the sum of annualized contract values |
| Includes | Recurring fees, expansions, renewals, after discounts | The same recurring amounts, annualized |
| Excludes | Setup, implementation, one-off projects, unpaid trials | The same one-time and non-recurring items |
| Best use | Month-to-month operations, churn, upgrades, short-term planning | Investor reporting, annual planning, valuation conversations |
| What it is not | Cash collected this month, or GAAP revenue | Cash in the bank, or your year-to-date P&L |
A worked example
Take a small product with a mixed book of business at the end of March:
- 40 customers on a $99 monthly plan: $3,960 of MRR
- 10 customers on a $1,200 annual plan: $100 each, or $1,000 of MRR
- $5,000 of one-time onboarding fees collected in March: $0 of MRR
Ending MRR is $4,960. ARR, using the run-rate definition, is $4,960 times 12, or $59,520.
Notice the trap. Those 10 annual customers may have paid $12,000 in cash in March if they all renewed the same week. Cash for the month could be $3,960 plus $12,000 plus $5,000, or $20,960. If you annualized the cash, you’d tell yourself you were a $251,520 business. You aren’t. A chunk of that cash was a prepayment you already counted in MRR at $100 a month, and $5,000 of it will not repeat unless you keep selling new onboarding. The recurring business is $59,520 ARR.
Now move one month. In April you add three new $99 customers ($297), one customer expands by $50, one $99 customer churns, and one customer downgrades by $50. Ending MRR is $4,960 + $297 + $50 minus $99 minus $50, which is $5,158. ARR is $61,896. That movement, new plus expansion minus churn minus contraction, is what operators watch every month. The ARR line is just that result expressed as a yearly run rate.
Which number investors and acquirers actually read
Stripe’s ARR guide is blunt about the audience: when investors assess a company, they typically look at growing ARR. Later-stage rounds, boards and many acquirers speak in ARR because it is a scale number they can compare across companies. They will also look at the quality behind it: growth rate, logo and revenue churn, net revenue retention, customer concentration, and whether the contracts are monthly, annual or something you can cancel tomorrow.
Operators should still live in MRR. A 2% monthly swing is hard to see if you only check an annualized headline once a quarter. Early conversations with seed investors often happen in MRR too, simply because the book of business is small and the month-to-month change is the story.
Acquirers of a subscription business usually start with ARR, then discount it. They are not going to pay a “SaaS price” on a number padded with setup fees, project work or one customer who is 40% of the book. That’s the same instinct behind how to value a small business: buyers pay for what reliably repeats. If you want a serious conversation, show ARR, show how you calculated it, and show the churn and concentration sitting underneath.
There’s no single official multiple I can quote you, and anyone selling you one without looking at growth, retention and margin is guessing. The number that starts the conversation is almost always ARR. The number that decides whether that ARR is real is built from the monthly components: new MRR, expansion, contraction and churn, plus how much of the book sits with a handful of customers. Net revenue retention is often the quality check sitting next to the ARR headline. This page won’t turn into a unit-economics primer, but if retention is weak, a pretty ARR will not stay pretty.
The mistakes that make both numbers lie
The most common one is multiplying this month’s cash by 12 and calling it ARR. Annual prepays and one-time invoices make that lie look professional.
The second is leaving one-time fees in the recurring figure because they happened to hit on a subscription invoice. If it does not repeat unless you sell it again, it is not recurring.
The third is forgetting to normalize. An annual contract belongs in MRR at one-twelfth. A quarterly plan belongs at one-third. If you drop the full invoice into “this month’s MRR,” you’ll invent a spike and then a crash.
The fourth is treating ARR as cash in the bank, or as the revenue line on your P&L. ARR is a run rate. Cash is what hit the account. Recognized revenue follows accounting rules, including deferrals for prepaid terms. If you’re still mixing those three, start with cash vs accrual accounting and keep ARR in its own column.
Seasonality will fool you too. A tutoring product, a tax tool or a retail app can have a fat March and a thin July. A single month annualized is a forecast that assumes nothing changes. Say so, or use a longer average and be honest about it.
Use both numbers. Watch MRR internally every month. Report ARR, and the definition you used, to anyone writing a check or buying the company. Just don’t ask either figure to do a job it wasn’t built for.
FAQ: ARR vs MRR
What is the difference between ARR and MRR?
MRR is the monthly value of recurring subscription revenue. ARR is that same recurring revenue expressed as a yearly run rate, most often as MRR times 12. They measure the same book of business on two clocks.
Is ARR just MRR times 12?
Often yes, and that is the formula Stripe and many SaaS operators use. Some annual-contract businesses instead sum annualized contract values. Either works if you pick one definition and stick to it.
Do one-time fees count toward MRR or ARR?
No. Setup, implementation, professional services and other non-recurring charges stay out of both numbers. Put them in a separate line so they don’t inflate the recurring run rate.
Which do investors care about, ARR or MRR?
Investors and acquirers typically start with ARR and whether it is growing. Operators and early-stage conversations often track MRR, because month-to-month new revenue, expansion and churn show up there first.
Is ARR the same as revenue on my income statement?
No. ARR is a run-rate metric, not GAAP revenue. Prepaid annual contracts can put cash in the door this month while recognized revenue is spread over the term.
How do annual contracts show up in MRR?
Divide the annual contract value by 12 and include that monthly amount in MRR for as long as the contract is active, not the full cash prepayment in the month it was billed.
Startups
Venture Debt: How It Works, Warrants and Covenants, and When It Beats Another Equity Round
Venture debt is a loan designed for venture-backed startups. It has to be repaid, and unlike a SAFE or a convertible note, it usually does not convert into equity. Banks and specialized non-bank lenders offer it, typically after, or alongside, an equity raise, as a way to add runway without selling as much of the company as another priced round would. J.P. Morgan’s October 17, 2024 explainer puts the distinction plainly: this is debt the lender expects to be repaid in full.
You’ll also hear a venture loan, a growth-capital term loan or, loosely, “a debt facility.” The sticker price is only part of the deal. Many facilities also include an origination fee, stock-purchase warrants and covenants that can limit what the company may do with cash, other borrowing, dividends or a sale. This is education, not a credit offer, and it is not a pitch for any lender. Talk to your board, your existing investors and a lawyer before you sign.
How venture debt actually works
Traditional bank loans are usually underwritten against cash flow or hard collateral. Early-stage companies often have neither. Venture lenders, as J.P. Morgan and Silicon Valley Bank (now part of First Citizens) describe in their educational materials, underwrite something else: the quality of the equity already in the company, and the likelihood that the company can raise more capital, or reach a point where it can repay, before the cash runs out.
The first rule those educational pages repeat is the one I would keep at the top of any term sheet: venture debt follows equity. It does not replace it. Companies that try to use a loan as a substitute for a round they could not raise are shopping for an umbrella in a storm. First Citizens’ explainer notes that creditworthiness and bargaining leverage are typically highest right after a fresh equity close, when the company is flush, and that soliciting debt when runway is already thin is usually harder and more expensive.
A common structure is a term loan with a short interest-only period, then principal and interest until maturity. Silicon Valley Bank’s educational chapter, excerpted by First Citizens, describes many growth-capital loans as needing to be repaid within three to four years, often with a six- to 12-month interest-only period at the start. J.P. Morgan’s 2024 note adds that some facilities amortize like a mortgage, and that an interest-only period followed by a single “bullet” repayment of principal is less common in bank venture lending. The schedule in your documents is the one that matters, not a market average.
Warrants, fees and why “non-dilutive” is a sloppy word
First Citizens lists three typical pricing pieces: the interest rate on the drawn balance, an origination fee, and stock-purchase warrants granted to the lender. Interest can be floating and, as J.P. Morgan notes, may be set off a published benchmark such as the Wall Street Journal prime rate. I am not going to invent a “typical” coupon. The rate is deal-specific, and it is only one line in the cost.
Warrants are the right to buy shares later at a set price, usually tied to a recent preferred round. If the company grows, the lender can share in some of that upside. The loan still has to be repaid even if the warrants are exercised. That is the opposite of SAFE vs convertible note economics, where the instrument is designed to become equity rather than to be paid back. Founders sometimes call venture debt “non-dilutive.” That is only half true. You are not selling a 20% primary round, but warrants are still a slice of the company, and the cash you will later use to repay the loan is cash you cannot spend on growth.
Covenants, and the lender’s view of burn
Covenants are the rules you agree to live under for the life of the loan. J.P. Morgan flags monthly financial reporting, performance tests, and limits on dividends, mergers and asset sales without lender consent. Some facilities also require a minimum cash balance, restrict additional borrowing, or, historically, ask that the company’s primary operating accounts sit with the lender. Breach can mean a default, a higher cost, or a demand for earlier repayment.
Lenders watch liquidity the way a founder should: cash, burn rate and runway, and whether the remaining months actually cover the milestone that makes the next raise, or repayment, realistic. First Citizens is blunt that companies with high burn are treated as riskier borrowers because they are even more dependent on outside capital “to fuel the burn.” If your plan is to borrow, keep spending at the same rate, and hope a higher valuation appears, you do not have a debt plan. You have a delay.
How large a facility, and when it can beat another equity round
There is no official size. First Citizens’ educational materials describe two common ways lenders size a loan: often around 25% to 35% of the most recent equity raise, or, as another rule of thumb they cite, roughly 6% to 8% of the last post-money valuation. J.P. Morgan, in that October 2024 note, said median U.S. venture-debt deal sizes had stayed in a range of $2.5 million to $5.3 million each year since 2014, with the upper quartile rising sharply after 2020. Those are dated reference points, not a target for your company.
Here is a labeled teaching sketch, not a real facility. A company has $4.8 million in the bank and burns $400,000 a month, which is 12 months of runway. A $1.2 million term loan, drawn up front, takes cash to $6 million, or 15 months, before any change in spend. During an interest-only period the early months barely move burn. When principal payments start, monthly cash out the door rises, and the extra runway shrinks unless revenue or a new raise arrives first. The loan only beats selling more equity if those extra months actually change the next conversation.
Used well, the product does a job equity is expensive at doing. You have just closed a round. You can see a milestone, hiring a sales team, finishing a product, or stretching a few more months, that would make the next raise cleaner or let you wait out a weak market. Silicon Valley Bank’s educational FAQ says a facility can provide on the order of three to nine months of additional capital, and that it is meant to supplement equity, not stand in for it. In that setting, a loan plus modest warrant dilution can be cheaper, in ownership terms, than selling another large primary round today.
Used badly, it stacks a repayment obligation on a company that already needed a raise. New equity investors may resist watching their money go out the door to pay off old debt. Too much leverage can constrain an exit, a later financing, or day-to-day spending once principal payments start, which is a risk J.P. Morgan lists explicitly. Seed-stage and friends-and-family-backed companies are often a poor fit, because lenders are underwriting the investors’ ability to follow on, not just the product.
What to look at besides the interest rate
First Citizens calls shopping only on price and loan size the biggest founder mistake. I agree with the instinct, even if I will not pick a lender for you. Read the covenants, the draw conditions, the prepayment rules, the warrant coverage and the circumstances that let the lender accelerate the loan. Ask how the lender has behaved when borrowers miss a plan, not only what they offer when the company is hitting it. And do the cash math in writing: interest and, later, principal, against a conservative burn, with a clear source of repayment.
Venture debt can be a smart complement to equity. It is still a loan. If you cannot explain, in one page, why the extra runway gets you to a better place and how the facility gets paid back, you are not ready to sign it.
Frequently Asked Questions
What is venture debt?
Venture debt is a loan for venture-backed startups that must be repaid and typically does not convert into equity. It is usually raised after, or alongside, an equity round to extend runway with less dilution than selling another large primary round.
How is venture debt different from a SAFE or a convertible note?
A SAFE or convertible note is designed to become equity at a later financing. Venture debt is a loan. Interest, fees and principal come due, and the loan stays payable even if the lender also holds warrants. J.P. Morgan’s 2024 explainer stresses that lenders expect to be repaid in full.
What are warrants in a venture debt deal?
Warrants give the lender the right to buy shares later at a set price, usually tied to a recent round. They are one reason venture debt is not fully non-dilutive. The loan still has to be repaid if the warrants are exercised.
What covenants show up in venture debt?
Common ones include financial reporting, minimum cash or performance tests, and limits on dividends, extra borrowing, mergers or asset sales without lender consent. Breaking a covenant can trigger default or early repayment. The actual list is in your loan agreement.
When does venture debt beat another equity round?
When you have recently raised equity, can see a milestone that extra runway would help you hit, and have a realistic way to repay or refinance. It is a poor substitute for an equity round you could not raise, especially if runway is already short.
How much venture debt can a startup raise?
There is no official amount. First Citizens’ educational materials cite common sizing around 25% to 35% of the last equity raise, or about 6% to 8% of the last post-money valuation. Actual facilities are deal-specific.
-
Did You Know1 year ago7 Surprising Life Lessons Video Games Taught Me That School Never Did
-
Life2 years agoThe 5 Stages of a Quarter-Life Crisis & What You Can Do
-
Success Advice1 year agoStephen Covey’s 8 Leadership Habits That Will Change How You Lead Forever
-
Life1 year agoHow to Stop the War in Your Head and Find Peace
-
Featured2 years agoThe Psychology of Motivation: How to Keep Moving Forward Every Day
-
Personal Development2 years agoThe Three-Second Pause That Changes How People Perceive You
-
Explode Your Social Media1 year agoWant More Views? Master These 6 YouTube Growth Tactics
-
Change Your Mindset1 year agoYou Become What You Absorb: How Input Shapes Your Life










4 Comments